Starling Oncology (STLNW) EBT Margin (2021 - 2026)
Starling Oncology's (STLNW) quarterly EBT Margin came in at 6.07% in Q2 2026, up 824.0% on a YoY basis from 0.66% in Q2 2025, and down 259.11% quarter-over-quarter from 1.69% in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) EBT Margin (2021 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported EBT Margin for 6 consecutive years, with 6.07% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 824.0% year-over-year to 6.07%; the trailing twelve-month figure through Jun 2026 stood at 6.18% (up 938.0% YoY), and the FY2025 full-year result was 12.08%, up 435.0% from the prior year.
- EBT Margin fell to 6.07% in Q2 2026 per STLNW's latest filing, from 1.69% in the prior quarter.
- Across five years, EBT Margin topped out at 35.29% in Q1 2022 and bottomed at 39.31% in Q1 2023.
- Historically, EBT Margin has averaged 12.31% across 5 years, with a median of 15.0% in 2025.
- The sharpest annual moves came in 2022 and 2023: EBT Margin soared 3689 bps in 2022, then plunged 7460 bps in 2023.
- Over 5 years, EBT Margin stood at 15.92% in 2022, then plunged by 40 bps to 22.23% in 2023, then jumped by 41 bps to 13.15% in 2024, then jumped by 60 bps to 5.29% in 2025, then declined by 15 bps to 6.07% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 6.07%, 1.69%, and 5.29% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.89 Bn | 11.20 Bn | 1.16 Bn | 12.24% |
| 2 | RadNet | 5.51 Bn | 4.78 Bn | 88.08 Mn | 4.27% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 7.88% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 14.74% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 2.65% |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - | 11.07% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 11.74% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 3.80% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 8.90% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -6.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.07% |
| Mar 31, 2026 | -1.69% |
| Dec 31, 2025 | -5.29% |
| Sep 30, 2025 | -12.09% |
| Jun 30, 2025 | -14.31% |
| Mar 31, 2025 | -18.76% |
| Dec 31, 2024 | -13.15% |
| Sep 30, 2024 | -16.13% |
| Jun 30, 2024 | -15.70% |
| Mar 31, 2024 | -21.01% |
| Dec 31, 2023 | -22.23% |
| Sep 30, 2023 | -21.07% |
| Jun 30, 2023 | -20.94% |
| Mar 31, 2023 | -39.31% |
| Dec 31, 2022 | -15.92% |
| Sep 30, 2022 | -4.15% |
| Jun 30, 2022 | -9.00% |
| Mar 31, 2022 | 35.29% |
| Dec 31, 2021 | -24.14% |
| Sep 30, 2021 | -4.17% |